Entero Therapeutics (GRDX) EPS (2016 - 2026)
Entero Therapeutics (GRDX) EPS from Sep 30, 2016 to Mar 31, 2026. The TTM Entero Therapeutics (GRDX) EPS is -$2.35. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Entero Therapeutics (GRDX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -87.72% |
| 3 Years TTM | -70.96% |
| 5 Years TTM | -78.95% |
| All Time TTM | -64.98% |
Annual EPS change of Entero Therapeutics (GRDX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.56 | -62.77% |
| 2025 | -$1.51 | -60.18% |
| 2024 | -$3.80 | -92.99% |
| 2023 | -$54.23 | -79.23% |
| 2022 | -$261.13 | -95.76% |
| 2021 | -$6,160.04 | -9.94% |
| 2020 | -$6,840.11 | -20.58% |
| 2019 | -$8,613.11 | -20.94% |
| 2018 | -$10,894.07 | -14.62% |
| 2017 | -$12,759.99 | -9.28% |
| 2016 | -$14,064.53 | N/A |
Comparison Entero Therapeutics (GRDX) five years EPS CAGR with competitors
Entero Therapeutics (GRDX) five years EPS CAGR is -79.78%.